Daiichi Life Insurance Co. Ltd. Purchases New Shares in Welltower Inc. $WELL

Key Points

• Daiichi Life Insurance purchased 72,001 Welltower shares worth approximately $16.3 million during the second quarter, joining several other institutional investors that established new positions. Institutions and hedge funds now own 94.8% of Welltower’s stock.
• Welltower shares opened at $239.95, near their 52-week high of $255.20, while analysts maintain a “Moderate Buy” consensus with an average price target of $246.11.
• The healthcare REIT reported quarterly revenue of $3.54 billion, up 39.1% year over year, though earnings per share missed estimates. Welltower also increased its quarterly dividend from $0.74 to $0.85, representing a 1.4% annualized yield.

Daiichi Life Insurance Co. Ltd. purchased a new position in shares of Welltower Inc. (NYSE:WELL - Free Report) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 72,001 shares of the real estate investment trust's stock, valued at approximately $16,342,000.

Several other hedge funds and other institutional investors have also bought and sold shares of WELL. Commerce Bank acquired a new position in shares of Welltower during the 2nd quarter worth approximately $5,836,000. Pinnbrook Capital Management LP acquired a new stake in shares of Welltower in the second quarter valued at approximately $5,788,000. Northwestern Mutual Wealth Management Co. acquired a new stake in shares of Welltower in the second quarter valued at approximately $15,416,000. WealthShield Partners LLC bought a new stake in shares of Welltower in the second quarter valued at approximately $328,000. Finally, Varma Mutual Pension Insurance Co bought a new stake in shares of Welltower in the second quarter valued at approximately $30,522,000. Institutional investors and hedge funds own 94.80% of the company's stock.

Welltower Stock Up 1.1%

Shares of WELL opened at $239.95 on Friday. Welltower Inc. has a one year low of $163.75 and a one year high of $255.20. The company has a market cap of $172.94 billion, a P/E ratio of 110.07, a P/E/G ratio of 1.14 and a beta of 0.76. The company has a debt-to-equity ratio of 0.37, a current ratio of 3.16 and a quick ratio of 3.16. The firm has a 50 day simple moving average of $232.48 and a two-hundred day simple moving average of $215.83.

Welltower (NYSE:WELL - Get Free Report) last issued its earnings results on Monday, July 27th. The real estate investment trust reported $0.61 earnings per share for the quarter, missing analysts' consensus estimates of $0.66 by ($0.05). Welltower had a net margin of 12.15% and a return on equity of 3.56%. The business had revenue of $3.54 billion during the quarter, compared to analyst estimates of $3.40 billion. During the same period in the prior year, the business posted $1.28 EPS. The company's revenue for the quarter was up 39.1% compared to the same quarter last year. Welltower has set its FY 2026 guidance at 6.360-6.440 EPS. Research analysts forecast that Welltower Inc. will post 6.44 EPS for the current fiscal year.

Welltower Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, August 20th. Investors of record on Wednesday, August 12th were paid a $0.85 dividend. This represents a $3.40 annualized dividend and a yield of 1.4%. This is a boost from Welltower's previous quarterly dividend of $0.74. The ex-dividend date of this dividend was Wednesday, August 12th. Welltower's payout ratio is 155.96%.

Analysts Set New Price Targets

A number of equities analysts have commented on the company. Wells Fargo & Company raised their price objective on Welltower from $228.00 to $237.00 and gave the stock an "overweight" rating in a research note on Monday, June 1st. Scotiabank cut their target price on Welltower from $248.00 to $232.00 and set a "sector outperform" rating for the company in a research report on Thursday, June 18th. Deutsche Bank Aktiengesellschaft increased their target price on Welltower from $215.00 to $265.00 and gave the stock a "buy" rating in a report on Wednesday, July 1st. Barclays initiated coverage on Welltower in a research note on Tuesday, July 7th. They issued an "equal weight" rating and a $254.00 price target for the company. Finally, Weiss Ratings cut shares of Welltower from a "buy (b-)" rating to a "hold (c+)" rating in a research report on Wednesday, June 24th. Fourteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $246.11.

Welltower Profile

Welltower Inc NYSE: WELL is a real estate investment trust (REIT) that acquires and manages real estate serving the health care industry. The company specializes in healthcare infrastructure, owning and operating a diversified portfolio of senior housing, post-acute and long-term care communities, and outpatient medical properties. Welltower's assets are designed to support the delivery of health care services through a combination of leased properties, joint ventures, and other capital arrangements with health care operators and providers.

The company's property types include assisted living, memory care, independent living and skilled nursing facilities, as well as medical office buildings and other outpatient-care real estate such as ambulatory surgery centers and specialty clinics.

Want to see what other hedge funds are holding WELL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Welltower Inc. (NYSE:WELL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source